Skip to content
Mar 03 2004
Equity Strategies

Sector Spotlight: Health Care

  • Mar 3, 2004

Conceptually we think that the big drug stocks are poised to rebound, but they have yet to rank Attractive in the Group Selection Scores.

tags

Health Care Biotechnology Weighting P/E EPS Pharmaceuticals Select Industries

Login

For full access, please enter your credentials.

About The Authors

Matt Paschke / Senior Research Analyst

Matt Paschke

Eric Bjorgen

current issue

featured articles

recent tags
[ALL]

Bank Lending (1) Wealth Effect (9) Resession (1) Dollar (55) Inflation (584) Time Cycles (6) Oil (48) Breakeven Rate (1) Value (130) Treasuries (79) Long T-Bonds (24) Active vs. Passive (17) Yield Curve (85) Economy (282) Federal Spending (2) Stock Market Performance (1) Federal Debt/Deficit (194) Fed Policy (173) Federal Outlays (1) Stimulus (4)